2014
DOI: 10.1038/ncomms4395
|View full text |Cite
|
Sign up to set email alerts
|

A recently evolved class of alternative 3′-terminal exons involved in cell cycle regulation by topoisomerase inhibitors

Abstract: Alternative 3 0 -terminal exons, which use intronic polyadenylation sites, are generally less conserved and expressed at lower levels than the last exon of genes. Here we discover a class of human genes, in which the last exon appeared recently during evolution, and the major gene product uses an alternative 3 0 -terminal exon corresponding to the ancestral last exon of the gene. This novel class of alternative 3 0 -terminal exons are downregulated on a large scale by doxorubicin, a cytostatic drug targeting t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
31
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 40 publications
(36 citation statements)
references
References 64 publications
5
31
0
Order By: Relevance
“…We thereby identified five molecules (SN38, camptothecin [CPT], febuxostat, T4 [6,7-dimethoxy-2-((4-phenyl-3,6-dihydropyridin-1 (2H)-yl)methyl) quinazoline-4(3H)-one], T5 [3-cyclobutyl-6-(2-naphthylmethyl)-2,7-dihydro-4H-pyrazolo [3,4-b]pyridin-4-one]) as hit compounds (Figures 1E and 1F). SN38 and CPT are topoisomerase inhibitors (TOPOi), which were previously reported to be APA modulators (Dutertre et al, 2014). This indicated that the initial cell-based reporter screen was sufficiently sensitive and specific to detect APA modulators.…”
Section: High-throughput Compound Screening With the Reporter Assaymentioning
confidence: 88%
See 1 more Smart Citation
“…We thereby identified five molecules (SN38, camptothecin [CPT], febuxostat, T4 [6,7-dimethoxy-2-((4-phenyl-3,6-dihydropyridin-1 (2H)-yl)methyl) quinazoline-4(3H)-one], T5 [3-cyclobutyl-6-(2-naphthylmethyl)-2,7-dihydro-4H-pyrazolo [3,4-b]pyridin-4-one]) as hit compounds (Figures 1E and 1F). SN38 and CPT are topoisomerase inhibitors (TOPOi), which were previously reported to be APA modulators (Dutertre et al, 2014). This indicated that the initial cell-based reporter screen was sufficiently sensitive and specific to detect APA modulators.…”
Section: High-throughput Compound Screening With the Reporter Assaymentioning
confidence: 88%
“…Chemical biology approaches have been useful to clarify the molecular mechanisms, regulation, and functions of cellular processes involved in RNA-processing pathways such as alternative splicing (Salton and Misteli, 2016). Topoisomerase inhibitors were reported to modulate CR-APA by dissociation from human antigen R in pre-mRNA (Dutertre et al, 2014). However, no APA-specific inhibitors or modulators have been identified.…”
Section: Introductionmentioning
confidence: 99%
“…For instance, HuR was shown to promote skipping of exon 6 in the transcript of the apoptosis receptor Fas, resulting in the generation of a soluble isoform that prevents programmed cell death 30 . HuR binding to the alternative 3′-terminal exon in pre-messenger target transcripts has been also shown to promote their splicing 31 . Since we have recently demonstrated that HuR constitutes a major mediator of hypotonicity-induced increase in MR expression under hypotoncity (see Lema et al ., 2017, submitted), we speculated that HuR might also participate to the processing of MR transcript in renal cells.…”
Section: Discussionmentioning
confidence: 99%
“…We depleted 174 proteins including all known factors involved in pre-mRNA 3'end cleavage and polyadenylation in eukaryotes 8 and selected key factors regulating transcriptional activities, splicing, RNA turnover and other functions [23][24][25][26][27][28][29][30][31][32] which could directly or indirectly modulate TREND ( Supplementary Table 2) 5 . Probing the efficiency of RNAi-mediated depletion revealed a dropout rate (i.e.…”
Section: Fig 3 | Massive Rnai Screening Reveals Key Regulators Of Trmentioning
confidence: 99%